ImmunityBio, Inc. IBRX
ImmunityBio, Inc. institutional holders
| Investor | Shares | Value | % of company |
|---|---|---|---|
| D. E. Shaw & Co., Inc. | 11,551,019 | $101.1M | 1.14% |
| TWO SIGMA INVESTMENTS, LP | 11,097,106 | $97.2M | 1.1% |
| BlackRock Finance, Inc. | 11,423,089 | $72.2M | 1.13% |
| CITADEL ADVISORS LLC | 5,674,645 | $49.7M | 0.56% |
| MILLENNIUM MANAGEMENT LLC | 5,579,793 | $48.9M | 0.55% |
| RENAISSANCE TECHNOLOGIES LLC | 1,029,399 | $9.0M | 0.1% |
| AQR CAPITAL MANAGEMENT LLC | 222,862 | $2.0M | 0.02% |
| Point72 Asset Management, L.P. | 132,000 | $1.2M | 0.01% |
% of company = reported institutional shares ÷ shares outstanding. Based on the latest reports; not every holder reports every quarter.
Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.